Renk GmbH
USPTO PatentsView assignee record - 24 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: F16H (Gearing).
The verdict
According to USPTO PatentsView, Renk ranks #12,642 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 21 technology areas.
- #12,642
- of 49,997 US assignees by volume
- Top 28%
- by Innovation Score (43.5/100)
- 11.1
- avg claims per patent
- +88%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R12642 · Foreign Corporation #12,642 · 24 grants
GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 24 grants
- MID-PACK #12,642/49,997
- PHOTO-FINISH Proteostasis…
- CPC-FOCUS F16H · 21 areas
- INNOV-PAR 43.5/100
- CLAIMS-PAR 11.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +88% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Proteostasis Therapeutics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Renk’s 43.5 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Renk
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Renk · this assignee
Renk · this assignee
44 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Renk's Innovation Score is 43.5/100 (top 28% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Renk?
Each dot is one of Renk’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Renk’s own 11.1 claims/patent is at or below the 16.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Renk's grants concentrate
Renk GmbH is a focused PatentsView assignee: 21 CPC subclasses with 45.8% of grants classified under F16H (Gearing). Peak complete grant year is 2023 (5 grants) versus a trough of 1 in 2015. By volume, Renk sits between Proteostasis Therapeutics, Inc. and Rodan & Fields, LLC.
Renk's three-year grant acceleration
Renk GmbH shows 10 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Renk's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Proteostasis Ther…
Proteostasis Therapeutics, Inc.
24 patents
- Rachio
Rachio, Inc.
24 patents
- Rade TecnologÍAS…
Rade TECNOLOGÍAS S.L.
24 patents
- Raumedic
Raumedic AG
24 patents
- Revance Therapeut…
Revance Therapeutics, Inc.
24 patents
- Riverfield
Riverfield Inc.
24 patents
- RKF Engineering S…
RKF Engineering Solutions LLC
24 patents
- Rodan & Fields
Rodan & Fields, LLC
24 patents
- Renk ◀
Renk GmbH
24 patents
What this shows Renk holds 24 patents at rank #12,640, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Renk
By rank, the assignees closest to #12,640 in granted patent volume.
- Proteostasis Therapeutics, Inc. #12,636 · 24 patents
- Rachio, Inc. #12,637 · 24 patents
- Rade TECNOLOGÍAS S.L. #12,638 · 24 patents
- Raumedic AG #12,639 · 24 patents
- Revance Therapeutics, Inc. #12,641 · 24 patents
- Riverfield Inc. #12,642 · 24 patents
- RKF Engineering Solutions LLC #12,643 · 24 patents
- Rodan & Fields, LLC #12,644 · 24 patents
Leaders in F16H (Gearing)
Other assignees with the most granted patents in Renk's primary technology class.
- Hyundai Motor Company 1,326 in class
- Toyota Jidosha Kabushiki Kaisha 1,070 in class
- ZF Friedrichshafen AG 904 in class
- Schaeffler Technologies AG & Co. KG 820 in class
- Ford Global Technologies, LLC 718 in class
- GM Global Technology Operations LLC 705 in class
- Honda Motor Co., Ltd. 660 in class
- KIA Motors Corporation 571 in class
Renk's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
44 Top 28% higher than 72% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 4.2% |
| 2016 | 2 | 8.3% |
| 2018 | 3 | 12.5% |
| 2019 | 2 | 8.3% |
| 2020 | 3 | 12.5% |
| 2021 | 2 | 8.3% |
| 2022 | 4 | 16.7% |
| 2023 | 5 | 20.8% |
| 2024 | 1 | 4.2% |
| 2025partial year | 1 | 4.2% |
Which technologies does Renk GmbH patent most?
Top 15 of 21 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Renk GmbH's patent record in context - here's where to go next.
- Renk GmbH's lead technology class is F16H (Gearing), 45.8% of its portfolio - see every assignee active in that class. Explore F16H
- Ranked #12,642 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Renk GmbH against Proteostasis Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 43.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.